Silo Pharma Statistics

Total Valuation

Silo Pharma has a market cap or net worth of $4.30 million. The enterprise value is -$1.15 million.

Market Cap	4.30M
Enterprise Value	-1.15M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Silo Pharma has 7.21 million shares outstanding. The number of shares has increased by 35.85% in one year.

Current Share Class	7.21M
Shares Outstanding	7.21M
Shares Change (YoY)	+35.85%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	3.45%
Float	6.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.82
Forward PS	n/a
PB Ratio	0.67
P/TBV Ratio	1.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.73

Current Ratio	4.73
Quick Ratio	4.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-931.88

Financial Efficiency

Return on equity (ROE) is -99.38% and return on invested capital (ROIC) is -66.11%.

Return on Equity (ROE)	-99.38%
Return on Assets (ROA)	-47.90%
Return on Invested Capital (ROIC)	-66.11%
Return on Capital Employed (ROCE)	-104.36%
Revenue Per Employee	$24,034
Profits Per Employee	-$1.54M
Employee Count	3
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.82% in the last 52 weeks. The beta is 1.52, so Silo Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-37.82%
50-Day Moving Average	0.74
200-Day Moving Average	1.11
Relative Strength Index (RSI)	47.25
Average Volume (20 Days)	2,178,330

Short Selling Information

The latest short interest is 67,438, so 0.94% of the outstanding shares have been sold short.

Short Interest	67,438
Short Previous Month	134,766
Short % of Shares Out	0.94%
Short % of Float	1.03%
Short Ratio (days to cover)	0.40

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$4.62 million in losses. Loss per share was -$1.13.

Revenue	72,102
Gross Profit	66,264
Operating Income	-4.92M
Pretax Income	-3.60M
Net Income	-4.62M
EBITDA	n/a
EBIT	-4.92M
Loss Per Share	-$1.13

Full Income Statement

Balance Sheet

The company has $5.45 million in cash and n/a in debt, giving a net cash position of $5.45 million or $0.76 per share.

Cash & Cash Equivalents	5.45M
Total Debt	n/a
Net Cash	5.45M
Net Cash Per Share	$0.76
Equity (Book Value)	4.01M
Book Value Per Share	0.89
Working Capital	4.42M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.64M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	91.90%
Operating Margin	-6,824.09%
Pretax Margin	-6,411.26%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.85%
Shareholder Yield	-35.85%
Earnings Yield	-107.45%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Silo Pharma has an Altman Z-Score of -3.93 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.93
Piotroski F-Score	1